,for, Item ID-
  • #1206997
  • Diazyme Laboratories #10-0148

General Chemistry Reagent PLAC® Lp-PLA2 For Automated Clinical Chemistry Analyzers 250 Tests

REAGENT, PLAC TEST F/LP-PLA2 R1 1X36ML R2 1X9ML (250/BX) D/S

No Image

Features

  • Diazyme's PLAC® Test is the only blood test cleared by the FDA to be used in conjunction with clinical evaluation and patient risk assessment as an aid in predicting risk of coronary heart disease (CHD) in patients with no prior history of cardiovascular events
  • The PLAC® Test for Lp-PLA2 Activity is an enzyme assay for the in vitro quantitative determination of Lp-PLA2 (lipoprotein-associated phospholipase A2) activity in EDTA plasma and serum on automated clinical chemistry analyzers
  • Lp-PLA2 activity is to be used in conjunction with clinical evaluation and patient risk assessment as an aid in predicting risk of coronary heart disease (CHD) in patients with no prior history of cardiovascular events
  • More …
  Log In to Order
or

Product Specifications


Features
  • Diazyme's PLAC® Test is the only blood test cleared by the FDA to be used in conjunction with clinical evaluation and patient risk assessment as an aid in predicting risk of coronary heart disease (CHD) in patients with no prior history of cardiovascular events
  • The PLAC® Test for Lp-PLA2 Activity is an enzyme assay for the in vitro quantitative determination of Lp-PLA2 (lipoprotein-associated phospholipase A2) activity in EDTA plasma and serum on automated clinical chemistry analyzers
  • Lp-PLA2 activity is to be used in conjunction with clinical evaluation and patient risk assessment as an aid in predicting risk of coronary heart disease (CHD) in patients with no prior history of cardiovascular events

Professionals Also Viewed